FDA Denies Citizen Petition to Protect Patients
Inside Health Policy covers FDA’s denial of CUSP’s Citizen Petition urging the FDA to recall a software that influences the prescribing of controlled medications.
FDA Denial of Petition to Protect Marginalized Patients
The FDA has denied CUSP’s Citizen Petition aimed at protecting patients from being deprived of the prescription drugs they need.
FDA Should Recall Software to Protect Patients
Axios reports on CUSP’s citizen petition asking the FDA to recall a widely used clinical decision support software.
Health Policy Advocates Oppose Federal Opioid Treatment Bill
Health policy advocates oppose federal opioid treatment bill to "authorize" methadone dispensing in pharmacies.
Health Policy Advocates Petition FDA to Recall Software
Inside Health Policy reports on CUSP’s Citizen Petition urging the FDA to initiate a recall of a widely-used clinical decision support software.
CUSP Files FDA Citizen Petition to Protect Patients
Petition seeks to recall software that unfairly limits access to prescription drugs.
Barnes to Speak at 2023 Rx Summit
Michael C. Barnes, Esq., Principal Attorney at Sequel Legal, will speak and moderate in-person at the 2023 Rx Drug Abuse & Heroin Summit in Atlanta, Georgia.
Center for U.S. Policy Welcomes Distinguished Leaders to Its Board of Directors
Ronne Ostby, M.A.; LaTonya Pinkard, M.Ed.; and Marsha Stanton, Ph.D., R.N., have been elected to CUSP's board of directors.
Consumers Must Make Informed Decisions Regarding Cannabinoids
The Center for U.S. Policy’s chairman publishes an opinion piece in CONQUER Magazine.
There Is Another Drug Reform Bill the Senate Must Pass
CUSP’s chairman urges the U.S. Senate to pass S.3257, a bill to remove an unnecessary barrier to treatment for opioid use disorder.
